SAM, CAM on TPG buy in Sai Lifesciences

Wednesday, 1 August 2018 By Legally India Private equity / VC

“American private equity firm TPG has acquired a significant minority stake in Sai Life Sciences, a drug discovery, development and manufacturing service provider,” reported Mint.

Shardul Amarchand Mangaldas managing partner Akshay Chudasama, principal associate Sayak Maity and senior associate Ankit Mishra acted for TPG with due diligence assistance from senior associate Aditi Tralshawala and associates Payal Chhabria and Neha Shaw.

Cyril Amarchand Mangaldas acted for Sai Lifesciences, led by Bangalore-based partners Arjun Lall and Nagavalli G.

Update 2 August 2018: PDS Legal acted for existing investor HBM Private Equity in relation to the transaction documentation, led by partner Vihang Virkar and director Ayesha Rai.

Shardul Amarchand MangaldasCyril Amarchand MangaldasPDS Legal

Comments

Curious Outsider 1 Aug 2018, 13:43
+1 -0
Do firms in India have pharma teams like they have in UK or US or do M&A lawyers do that.
Yes 1 Aug 2018, 17:00
+0 -5
Believe NDA is good at pharma, and also has a doctor as partner to focus on this area
Ex Khaitan 1 Aug 2018, 17:43
+1 -10
Khaitan has few rockstar partners who specialize in Pharma!!
Ex Client 2 Aug 2018, 10:33
+4 -0
Making photocopies of a single writ draft and filing for peanuts simply by changing the memo of parties and paras 1,2 and 3 does not make you a specialist in pharma. You need to understand the industry, keep on top of latest developments and moreover demonstrate more than textbook knowledge.
Ok 2 Aug 2018, 14:07
+0 -1
Why's a pharma client commenting on Legally India posts about Khaitan. Kaafi suspicious
Badbad 2 Aug 2018, 15:44
+1 -0
Maybe the writ was dismissed.
Guest 2 Aug 2018, 07:22
+3 -0
Lol doctor as a pharma expert!
Kissan 2 Aug 2018, 08:41
+0 -1
Indeed. I was expecting that the'll hire only farmers as pharma experts! Doctor doesn't make sense.
Transl. scientist 2 Aug 2018, 10:32
+1 -0
'Cause doctors know so much about dissociation constants and drug kinetics, right? Or the process of drug discovery from in silico processes to synthesis to animal to human trials?
Helpful Insider 1 Aug 2018, 14:12
+8 -3
Cyril Amarhand has dedicated lawyers who focus on Pharma, Life Sciences & Bio Tech etc. Happy to send you further details, if you like?
Lol 2 Aug 2018, 07:12
+12 -7
How is this not solicitation?
BCI 2 Aug 2018, 08:16
+8 -3
Sab ko andar karo!
Observation 2 Aug 2018, 14:45
+2 -0
A certain Khaitan partner had some good TPG work coming in, which ultimately went SAM's way. I wonder if this was picked up in his review.
Commenting is closed for this article.